The HICCC is pleased to announce a fifth Irving Cancer Drug Discovery Program (ICDDP) project, designed to help faculty accelerate cancer research discoveries.
HICCC's research team, led by Carla Concepcion-Crisol, PhD (PI); and Benjamin Herzberg, MD, will focus on evaluating SMARCA4-mutant non-small cell lung cancer.
New support from the MacMillan Family Foundation will address the urgent need for targeted interventions and community-driven solutions for disparities in cancer care.
Nine clinical investigators and trainees at the Herbert Irving Comprehensive Cancer Center will receive awards from Conquer Cancer®, the ASCO Foundation, this year at ASCO's 2023 Annual Meeting
Dr. Izar has been selected as a recipient of the Pershing Sohn Prize in recognition of his innovative approach to finding a new therapeutic target for brain metastasis.
With grant support from the V Foundation, Dr. Cheng will pursue innovative research studying the interface of nutritional and gene regulatory networks in cancer.
Cory Abate-Shen, PhD, an internationally-recognized expert in genitourinary cancer, has been selected as the 2023 recipient of the AACR's Women in Cancer Research Charlotte Friend Lectureship.
HICCC Director Anil Rustgi, MD, is being honored for his major contributions in advancing the care of patients with digestive diseases through clinical or translational research.
The CZI Diversity award recognizes the Azizi lab with a new $1.15M grant and underscores Dr. Azizi's commitment to improving diversity and inclusion in cancer science, engineering, and research.